MSNBC correspondent and “Into America” podcast host Trymaine Lee moderates a conversation with Dr. Marcella Nunez-Smith, chair of the COVID-19…
Search / 132 results found Showing: 1-10 of 132
With the U.S. pause of Johnson & Johnson’s COVID-19 vaccine stretched into a second week, authorities are weighing whether to resume the shots the way European regulators decided to -- with warnings of a “very rare” risk.
Confronted with rare cases of blood clots potentially linked to Johnson & Johnson’s COVID-19 vaccine, U.S. health officials faced a delicate task: how to suspend distribution of the shots without setting off alarm about their safety.
The European Union’s drug regulatory agency said Tuesday that it found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and extremely rare blood clots and recommended a warning be added to the label.
Local health care leaders and journalists are coming together via a webinar to share tools and ideas for increasing vaccine uptake among specific populations in Kentucky, including Black, rural, and Spanish-speaking communities.
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
Ultimately, the guidance may do little, as people are already traveling extensively nationwide.
Johnson & Johnson has started testing its coronavirus vaccine in adolescents. The company says it has expanded its Phase 2a trial, which began last September, to now include teens between the ages of 12 and 17.
The company at the center of quality problems that led Johnson & Johnson to discard an unknown amount of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems.
More than 60,000 of pregnant women have rolled up their sleeves for their first dose, but many moms or moms to be may still have questions and concerns about safety. A local OBGYN weighs in on the safety and mothers share their experience.